REGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), March 31, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 4,859,382.45 Total number […]
Read moreCategory: Press Releases
Gorilla Technology to Announce Full Year 2022 Results and Host Conference Call
LONDON, March 31, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and cybersecurity, announced today that the company’s full year 2022 financial results will be released after the U.S. financial markets close on Tuesday, April 4, 2023. The Company will host a […]
Read moreTelesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Kit product line, releasing […]
Read moreMarco Tognon wins the Superyacht Chef Competition at the Yacht Club de Monaco
MONACO, March 31, 2023 (GLOBE NEWSWIRE) — Marco Tognon won the Superyacht Chef Competition at the Yacht Club de Monaco. The event was held for the fourth year at the YCM in partnership with Bluewater and under the aegis of YCM’s La Belle Classe Academy training centre and the Monaco, Capital of Advanced Yachting approach. […]
Read moreJunshi Biosciences Announces 2022 Full Year Financial Results and Provides Corporate Updates
SHANGHAI, China, March 31, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced financial results for the 2022 full year and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB 1,453 million […]
Read more2023 Digital Therapeutics Alliance Inaugural Summit: DTx Industry Leaders Gather to Transform Global Healthcare
Held at the Washington D.C. Marriott at Metro Center June 7 – 9, 2023.The 3-day Summit programming will be facilitated by leaders from all facets of the DTx industry, including policymakers, manufacturers, payors, and other experts to guide innovation and equity in healthcare. Arlington, VA, March 30, 2023 (GLOBE NEWSWIRE) — The Digital Therapeutics Alliance […]
Read moreResMed Chief Administrative Officer and Global General Counsel to Retire
ResMed to conduct an internal search for a successor general counsel Amy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive leadership team SAN DIEGO, March 30, 2023 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) announced today that David Pendarvis, chief administrative officer, global general counsel, and secretary, plans to retire, […]
Read moreThe New Zealand Qualifications Authority and World Education Services Partner on Qualifications Recognition for Migrants with International Education
WELLINGTON, New Zealand, March 30, 2023 (GLOBE NEWSWIRE) — The New Zealand Qualifications Authority (NZQA) and World Education Services (WES) have signed an agreement to streamline qualifications assessment for migrants to New Zealand who hold credentials from another country. Under the agreement, WES will provide qualification verification services to immigration applicants to New Zealand. “NZQA […]
Read more